A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.

Completed · Phase 3

Conditions studied: Contraception

In brief

This study is being conducted to evaluate the safety of ethinyl an extended-regimen oral contraceptive, with ethinyl estradiol supplementation during the usual hormone-free week, for up to an additional three consecutive years.

Key facts

Study ID

NCT00196352

Run by

Duramed Research

People needed

320

Starts

2003-05-01

Expected to finish

2006-11-01

Last updated by the study team

2014-04-08

Who can join

Age: 18 and older, up to 40. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Participant in the earlier Phase 3 Seasonique clinical trial

You may not qualify if…

• Any contraindication to the use of oral contraceptives

Where it is running

• Duramed Investigational Site — Tucson, Arizona, United States
• Duramed Investigational Site — Washington D.C., District of Columbia, United States
• Duramed Investigational Site — Lincoln, Nebraska, United States
• Duramed Investigational Site — Rochester, New York, United States
• Duramed Investigational Site — Charlotte, North Carolina, United States
• Duramed Investigational Site — Winston-Salem, North Carolina, United States
• Duramed Investigational Site — Columbus, Ohio, United States
• Duramed Investigational Site — Oklahoma City, Oklahoma, United States
• Duramed Investigational Site — Nashville, Tennessee, United States
• Duramed Investigational Site — Arlington, Virginia, United States
• Duramed Investigational Site — Norfolk, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.